explore -WSS

explore

author：fashion 2025-08-23 04:56:53 - browse：9

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Wildfire pollution widens asthma inequities on Long Island

explore

WSS

What to expect as Trump is arraigned on his Jan 6. indictment

Why we need mandatory labeling of GMO products

Mega Millions pot grows to $1.25 billion after no winner

Protect nursing home residents from future pandemics

EQRx, failed developer of low

Pharma’s losing bet in New Jersey

focus

explore

leisure time

What does generative AI mean for health care? We asked experts

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

23andMe had bad news about my health. I wish a person had delivered it

NIH launches clinical trials and new research office for long Covid

Moonlake's readout produced a cash windfall. Risks remain

5 important ways Henrietta Lacks changed medical science

Drug repurposing or repositioning? The language matters

J&J reports mixed data on next

Drug repurposing or repositioning? The language matters

J&J reports mixed data on next

hotspot

Why some fertility treatments produce more boy babies

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Bird flu makes raw milk dangerous to consume, mouse study finds

Ozempic cut risk of death in diabetes patients with chronic kidney disease

leisure time

explore

explore

hotspot